세계의 뇌파 측정장치 시장은 2023년에 14억 8,000만 달러에 달했으며, 2033년에는 30억 8,000만 달러에 이를 것으로 예측되며, 예측기간 2025-2033년의 CAGR은 7.4%를 나타낼 전망입니다.
뇌파는 두피에 부착된 작은 센서를 사용하여 두뇌 활동을 기록하는 통증이 없는 검사입니다. 이러한 신호는 일반적으로 임상 신경생리학자인 의사가 분석합니다. 뇌파는 반복적인 발작을 일으키는 간질과 같은 다양한 뇌 상태를 진단하고 모니터링하는 데 도움이 될 수 있습니다. 뇌파의 주요 용도는 뇌전증을 감지하고 조사하여 의사가 뇌전증의 유형, 유발 요인 및 환자에게 가장 적합한 치료법을 파악하는 데 도움을 주는 것입니다. 이 절차는 일반적으로 병원 방문 시 고도로 훈련된 전문가가 수행합니다.
촉진요인과 억제요인
기술 발전 증가
기술 발전은 뇌파 데이터 캡처, 분석 및 활용을 혁신함으로써 세계의 뇌파 검사(EEG) 장치 시장의 중요한 추진 요인 중 하나입니다. 무선 및 웨어러블 뇌파 장치는 휴대성과 사용자 편의성을 향상시켜 임상 및 비임상 환경에서 실시간 모니터링을 가능하게 합니다. 고밀도 뇌파 시스템과 향상된 센서 기술은 뇌 활동 매핑 정확도를 향상시켜 더 나은 신경학적 진단을 가능하게 합니다. AI와 머신러닝 알고리즘의 통합은 데이터 해석을 혁신하여 복잡한 신경학적 상태에 대한 보다 빠르고 정확한 분석을 가능하게 합니다. 클라우드 기반 데이터 스토리지와 IoT 지원 장치는 원격 의료, 게임, 인지 연구 전반에 걸쳐 뇌파 기술의 적용 범위를 넓히고 있습니다.
예를 들어, 2024년 4월, 소테릭스 메디컬은 모바일 및 자연 환경에서의 연구 애플리케이션을 위해 고해상도 경두개 전기 자극(HD-tES)과 EEG 시스템을 결합한 MxN-GO EEG를 출시했습니다. 가볍고 선이 없는 이 시스템은 33개의 자극 채널과 32개의 기록 채널을 제공하여 탁월한 정밀도와 애플리케이션별 타겟팅을 제공합니다. mBrainTrain과 공동으로 개발한 이 시스템은 빠른 설정과 사용 편의성을 위해 설계되어 모바일 하이브리드 자극/EEG 연구를 위한 최고의 솔루션을 제공합니다.
숙련된 전문가 부족
세계의 뇌파(EEG) 장치 시장은 숙련된 전문가 부족으로 인해 첨단 기술의 완전한 활용이 제한되는 문제에 직면해 있습니다. 정확한 뇌파 기록 및 분석을 위해서는 전극 배치, 신호 수집, 복잡한 뇌파 데이터 해석에 대한 전문 지식이 필요한데, 특히 신흥 시장에서는 의료 환경에서 이를 구하기 어려운 경우가 많습니다. 이러한 인력 부족은 간질이나 수면 장애와 같은 신경학적 질환의 진단 정확도를 떨어뜨리고 뇌파 데이터에 의존하는 연구 이니셔티브에 영향을 미칩니다.
The global electroencephalography devices market reached US$ 1.48 billion in 2023 and is expected to reach US$ 3.08 billion by 2033, growing at a CAGR of 7.4% during the forecast period 2025-2033.
An electroencephalogram (EEG) is a painless test that records brain activity using small sensors attached to the scalp. These signals are analyzed by a doctor, usually a clinical neurophysiologist. EEGs can help diagnose and monitor various brain conditions, such as epilepsy, which causes repeated seizures. The main use of EEGs is to detect and investigate epilepsy, helping doctors identify the type of epilepsy, triggers, and the best treatment for the patient. The procedure is usually carried out by a highly trained specialist during a hospital visit.
Market Dynamics: Drivers & Restraints
Rise in the Technological Advancements
Technological advancements are one of the significant driving factors in the Global Electroencephalography (EEG) Devices Market by revolutionizing brainwave data capture, analysis, and utilization. Wireless and wearable EEG devices enhance portability and user convenience, enabling real-time monitoring in clinical and non-clinical settings. High-density EEG systems and improved sensor technology improve brain activity mapping accuracy, enabling better neurological diagnosis. The integration of AI and machine learning algorithms transforms data interpretation, enabling faster, more precise analysis for complex neurological conditions. Cloud-based data storage and IoT-enabled devices broaden EEG technology's application across telemedicine, gaming, and cognitive research.
For instance, in April 2024, Soterix Medical has launched the MxN-GO EEG, a combined High Definition transcranial Electrical Stimulation (HD-tES) and EEG system designed for research applications in mobile and natural environments. The lightweight, wire-free system offers 33 stimulation channels and 32 recording channels, providing unparalleled precision and application-specific targeting. The system, developed in collaboration with mBrainTrain, is designed for rapid set-up and ease of use, offering the ultimate solution for mobile hybrid stimulation/EEG studies.
Lack of Skilled Professionals
The Global Electroencephalography (EEG) Devices Market faces challenges due to a shortage of skilled professionals, limiting the full utilization of advanced technologies. Accurate EEG recording and analysis require expertise in electrode placement, signal acquisition, and interpreting complex brainwave data, which is often unavailable in healthcare settings, especially in emerging markets. This shortage hampers diagnostic accuracy for neurological conditions like epilepsy and sleep disorders and affects research initiatives relying on EEG data.
For more details on this report - Request for Sample
The global electroencephalography devices market is segmented based on product type, application, technology, end user and region.
Portable EEG Devices segment is expected to dominate the Electroencephalography Devices market share
The portable EEG devices segment holds a major portion of the electroencephalography devices market share and is expected to continue to hold a significant portion of the electroencephalography devices market share during the forecast period.
Portable EEG devices are revolutionizing the Global Electroencephalography (EEG) Devices Market by providing accessibility and convenience in neurological diagnostics and monitoring. These devices are designed for mobility, allowing patients to undergo testing outside traditional clinical settings, particularly for conditions like epilepsy, sleep disorders, and brain injuries. Equipped with advanced wireless technologies, they enable real-time data transmission and integration with digital platforms for analysis and storage. Their compact design and user-friendly interfaces make them suitable for telemedicine applications, expanding their reach to underserved or remote areas.
For instance, in April 2024, NeuroVigil has launched its iBrain personal brain monitor in the U.S., a noninvasive device that records brain electrical activity in individuals with neurological conditions. The device, based on electroencephalogram (EEG) technology, can be used at home and during sleep for efficient and user-friendly EEG data collection. In the second phase, a smaller version will be used to detect signs of Parkinson's disease.
Application:-
Disease Diagnosis segment is the fastest-growing segment in Electroencephalography Devices market share
The disease diagnosis segment is the fastest-growing segment in the electroencephalography devices market share and is expected to hold the market share over the forecast period.
The Global Electroencephalography (EEG) Devices Market is driven by the need for early diagnosis and monitoring of various neurological conditions. EEG devices are used for detecting epilepsy, Alzheimer's, Parkinson's, stroke, and brain tumors. They also aid in diagnosing sleep disorders like insomnia and obstructive sleep apnea by monitoring brain activity during sleep cycles. The increasing prevalence of these disorders and the focus on early detection and personalized treatment have driven the demand for advanced EEG systems, including portable and wearable devices. This underscores the crucial role of EEG in improving neurological healthcare outcomes globally.
For instance, in December 2024, LVIS Corporation has launched NeuroMatch Access, a cloud-based SaaS platform designed to streamline EEG diagnostics review and improve physician collaboration. The platform, now available in the US, enables neurologists to quickly review and interpret EEG data, enabling real-time collaboration for more accurate and timely diagnoses. NeuroMatch, a cutting-edge technology that uses artificial intelligence to remove unwanted artifacts, enables clinicians to visualize and understand brain circuit communication pathways, facilitating targeted interventions and restorative strategies to enhance neurological health.
North America is expected to hold a significant position in the Electroencephalography Devices market share
North America holds a substantial position in the electroencephalography devices market and is expected to hold most of the market share due to advanced healthcare infrastructure and increasing prevalence of neurological disorders like epilepsy, Alzheimer's, and Parkinson's. Demand for EEG devices is driven by high awareness of early diagnosis and treatment, company's partnerships, government and private funding for neuroscience research, widespread adoption of advanced devices like portable and wearable EEG systems, and ongoing innovation in AI and machine learning integration.
For instance, in January 2024, Gate Neurosciences has partnered with Beacon Biosignals to advance the use of electroencephalogram (EEG) biomarkers in neuropsychiatry and cognition. The collaboration will use Beacon Biosignals' Dreem 3S headband device and neurobiomarker platform to conduct exploratory EEG and sleep analyses in depressed patients enrolled in Gate's Phase 2 trial of zelquistinel, a rapid-acting, once-weekly oral NMDA receptor positive modulator for treating major depressive disorder.
Europe is growing at the fastest pace in the Electroencephalography Devices market
Europe holds the fastest pace in the electroencephalography devices market and is expected to hold most of the market share due to a increased healthcare investments and focus on mental health and neurological research. The increasing incidence of neurodegenerative diseases and sleep disorders in the aging population necessitates advanced diagnostic tools like EEG. Government initiatives and research grants are also driving this growth. The adoption of digital health solutions and home-based and telehealth monitoring further supports the EEG market expansion.
For instance, in December 2024, Neuroelectrics and Neuronostics have partnered to offer an integrated EEG solution for pharmaceutical, contract research organisations, and academic partners. The partnership combines Neuroelectrics' advanced EEG hardware with Neuronostics' proprietary analytics to streamline clinical trials and unlock new possibilities in neurological research. The platform enhances cohort identification, streamlines protocol design, and delivers precise EEG analysis, ensuring trials are efficient and impactful. This partnership addresses the critical need for high-quality, actionable data in clinical trials.
The major global players in the electroencephalography devices market include Natus Medical Incorporated, Compumedics Limited, Nihon Kohden Corporation, Medtronic plc, Neurosoft, Micromed Group, Cadwell Industries, Inc, Electrical Geodesics, Inc (Philips Healthcare) Brain Products GmbH, Advanced Brain Monitoring, Inc and among others.
The global electroencephalography devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
LIST NOT EXHAUSTIVE